{"id":212277,"name":"INSULET CORPORATION","slug":"insulet-corporation","state":"MA","country":"United States of America","description":"","totalSpending":1270000,"filings":18,"yearlySpending":[{"year":2021,"income":10000},{"year":2022,"income":190000},{"year":2023,"income":280000},{"year":2024,"income":370000},{"year":2025,"income":420000}],"issues":[{"code":"PHA","display":"Pharmacy"},{"code":"MAN","display":"Manufacturing"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"INS","display":"Insurance"},{"code":"TEC","display":"Telecommunications"},{"code":"HCR","display":"Health Issues"}],"firms":["INSULET CORPORATION"],"lobbyists":["AL LYTTON"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","HOUSE OF REPRESENTATIVES","SENATE","Office of Management & Budget (OMB)"],"sampleDescriptions":["Medical Device Manufacturing, medicare/medicaid reimbursement, market access issues, telehealth issues, data and cybersecurity, digital health, diabetes disease specific issues","Medical Device Manufacturing, medicare/medicaid reimbursement, market access issues, telehealth issues, data and cybersecurity, digital health, diabetes disease specific issues","Medical Device Manufacturing, medicare/medicaid reimbursement, market access issues, telehealth issues, data and cybersecurity, digital health, diabetes disease specific issues","Medical Device Manufacturing, medicare/medicaid reimbursement, market access issues, telehealth issues, data and cybersecurity, digital health, diabetes disease specific issues","Medical Device Manufacturing, medicare/medicaid reimbursement, market access issues, telehealth issues, data and cybersecurity, digital health, diabetes disease specific issues"]}